These days, Biotherapeutics are the rapidly growing group of pharmaceuticals, actually for a treatment option, a variety of chronic and sometimes life-threatening conditions. Those represent a dissimilar group of biological preparations that widely encompasses nucleic acids, proteins, whole cells, viral particles, and vaccines.
In recent years, great progress has been made regarding the development of safe and effective Biotherapeutics, and in the adoption of cost-effective, more efficient, and modernized manufacturing processes. This trend looks forward to accelerating in the forthcoming years, as emerging fields related to advanced therapies or personalized medicine mature.
Advances in Drug Discovery and Development
Any Procedure which is applied to drug discovery and development by the medical community and pharmaceutical industry has a direct change in the further availability of better, innovative, and therapeutic treatment for patients with cancer. Drug discovery is defined as a complicated learning technique whereby research efforts are directed towards discover and assimilating new innovative thoughts to produce a drug to provide a benefit to a patient population.
Subsequently, a highly useful technology or approach to drug discovery should give both effective thoughts and the applications of newly discovered observations that can be utilized for therapeutic benefit.
Title : Drug Delivery to Stem Cells in Regenerative Medicine
Esmaiel Jabbari, University of South Carolina, USA
Title : Targeted nanoparticles for diagnostic and theranostic applications
Paul Millner, University of Leeds, UK
Title : Nanostructured Formulations in Skin Cancer: Challenges and Perspectives
Daniela Monti, University of Pisa, Italy
Title : Introducing the Sorush Cancer Treatment Protocol (SCTP)
Sorush Niknamian, Violet Cancer Institute, USA
Title : Hydrogen Sulfide: A Stinky Gas….. and Novel Therapeutic Target for Inflammatory Disease
Madhav Bhatia, University of Otago, Newzealand
Title : Assessment an umbilical cells induced neuroplasticity in patients with schizophrenia using functional MRI
Dmitry Ustyuzhanin, National Medical Research Center of Cardiology, Russia
Title : Evaluation of drug permeability in blood-brain barrier in vitro models
Anna Caprifico, Kingston University, UK
Title : Bryophyllum pinnatum Compounds Inhibit the Oxytocin-Induced Pathways in Human Myometrial Cells
Stefanie Santos, University Hospital Zurich, Switzerland
Title : Cancer: is there any hope?
Ranjita Shegokar, Capnomed GmbH, Germany
Title : Process innovation in the production of smart lipid-polymeric release systems
Annalisa Dalmoro, University of Salerno, Italy